Also in January 2025, the EMA announced that its Pharmacovigilance Risk Assessment Committee had started a review of medicines containing semaglutide, following concerns over links to an increased risk of patients developing a rare eye condition
Clinical Trial Findings: Quantification of IL-6, MDA, and GSH Levels in T2DM Subjects Levels of IL-6 were quantified in plasma and PBMCs isolated from T2DM subjects at pre- and post- L-GSH/or placebo supplementation
The new recommendations from the expert panel from both societies, which update their previous 2015 guidance, include: Providers and healthcare systems should prioritise the delivery of patient-centred care Facilitating medication adherence should be specifically-considered when selecting glucose-lowering medications
Patients complete intake questionnaires, speak with a provider, and receive peptide prescriptions if deemed appropriate
This policy applies to all insurance companies, including federal health insurance programs like Medicare
The analysis is provided exclusively for informational purposes and should not be considered professional investment advice